Literature DB >> 26070768

Increased homocysteine levels correlate with the communication deficit in children with autism spectrum disorder.

Carmen Puig-Alcaraz1, Milagros Fuentes-Albero2, Jesús Calderón3, Dolores Garrote4, Omar Cauli5.   

Abstract

The clinical significance of high levels of homocysteine in autism spectrum disorder (ASD) is unknown. An experimental study was conducted in order to evaluate the concentration of homocysteine in children with ASD and typically developing children and to analyse any relationships with the severity of core symptoms of ASD and other clinical features (drugs, co-morbidities, gender, age, diet). Core symptoms of autism were evaluated by DSM-IV criteria. Homocysteine, glutathione, methionine, 3-nitrotyrosine were measured in urine. The increase in homocysteine concentration was significantly and directly correlated with the severity of the deficit in communication skills, but was unrelated to deficit in socialisation or repetitive/restricted behaviour. Urinary homocysteine concentration may be a possible biomarker for communication deficits in ASD and a potential diagnostic tool useful to evaluate new treatment options since no treatment for core symptoms of ASD are available.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Autism spectrum disorder; Biomarker; Core symptoms; Homocysteine; Language development; Metabolism

Mesh:

Substances:

Year:  2015        PMID: 26070768     DOI: 10.1016/j.psychres.2015.05.021

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  The Impact of Inhaled Ambient Ultrafine Particulate Matter on Developing Brain: Potential Importance of Elemental Contaminants.

Authors:  Deborah A Cory-Slechta; Marissa Sobolewski; Elena Marvin; Katherine Conrad; Alyssa Merrill; Tim Anderson; Brian P Jackson; Gunter Oberdorster
Journal:  Toxicol Pathol       Date:  2019-10-14       Impact factor: 1.902

Review 2.  Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Afaf El-Ansary; Mona A El-Bana; Maryam Dadar; Jan Aaseth; Maha Hemimi; Joško Osredkar; Salvatore Chirumbolo
Journal:  J Mol Neurosci       Date:  2018-10-24       Impact factor: 3.444

Review 3.  Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review.

Authors:  Jet B Muskens; Fleur P Velders; Wouter G Staal
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-07-03       Impact factor: 4.785

Review 4.  Oxidative Stress in Autism Spectrum Disorder-Current Progress of Mechanisms and Biomarkers.

Authors:  Xukun Liu; Jing Lin; Huajie Zhang; Naseer Ullah Khan; Jun Zhang; Xiaoxiao Tang; Xueshan Cao; Liming Shen
Journal:  Front Psychiatry       Date:  2022-03-01       Impact factor: 4.157

5.  Efficacy of Folic Acid Supplementation in Autistic Children Participating in Structured Teaching: An Open-Label Trial.

Authors:  Caihong Sun; Mingyang Zou; Dong Zhao; Wei Xia; Lijie Wu
Journal:  Nutrients       Date:  2016-06-07       Impact factor: 5.717

Review 6.  Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature.

Authors:  Hui-Fei Zheng; Wen-Qiang Wang; Xin-Min Li; Gail Rauw; Glen B Baker
Journal:  Amino Acids       Date:  2016-09-29       Impact factor: 3.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.